Title Credit Start and expiration dates Member price Non-member pricesort descending
Management of Hypertension and the Use of Ambulatory Blood Pressure Monitoring
0.75 NAPNAP Contact Hour, 0.25 Pharmacology Hour. This continuing education activity rate is 5$ for NAPNAP Members and for non- members. This course will include prevalence and etiologies of high blood pressure in children and how to most accurately identify those patients who will require medical intervention. The presenters discussed evidence-based first and second line treatment, including recommended diagnostic and clinical monitoring. The role of the nurse practitioner in managing pediatric patients with concerns of high blood pressure will provide a unique view of changing practices.
    • 0.75 Contact hours
05/10/2019 to 06/30/2021 $5.00 $5.00
ADHD 300: Beyond the Basics
1.0 NAPNAP Contact Hour 0.5 Pharmacology Hours 1.0 Psychopharmacology 0.5 controlled substance. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is 10$. The purpose of this presentation is to have a case-based discussion to increase primary care provider (PCP) confidence in caring for children with ADHD symptoms who have other co-morbidities and those who do not have successful clinical response to first medication use. Included in the discussion are the diagnostic criteria for ADHD, anxiety, autism and explosive anger disorder; the guidelines for screening and diagnosis; and discussion of the pharmacologic therapies that reduce core symptoms of the conditions. The presenter will address controversies in prescribing and the realities of clinical primary care management.
    • 1.00 Contact hours
06/15/2020 to 12/31/2021 $0.00 $10.00
2021 Immunization Update – Focus on the Schedule
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is 10$. While sharing the latest CDC immunization information, Dr. Koslap-Petraco will share real life experiences and case studies to engage and challenge you to educate and vaccinate your patient families, especially those who question the need for vaccines.
    • 1.00 Contact hours
03/24/2021 to 04/30/2022 $0.00 $10.00
Truth or Consequences from the NoseBleed Seats
0.5 NAPNAP Contact Hour. This continuing education activity is offered free NAPNAP Members. For non- members, this continuing education activity rate is 10$. This CE provides an overview of nose bleed causes with differential diagnoses and treatment information.
    • 0.50 Contact hours
06/23/2020 to 07/31/2021 $0.00 $10.00
2021 Food Allergy Prevention Update: Introducing allergens into an infant’s diet
1.0 NAPNAP contact hour. This continuing education activity is offered free NAPNAP Members. For non- members, this continuing education activity rate is 10$. A recent publication was released with new guidelines to early introduction of foods to prevent food allergies. Dr. Shroba, who previously presented on the Food Allergy Prevention course will update you on the most important facts of this new research. You will be able to asses infant’s levels of risk for development of a food allergy. You will also learn how to counsel parents on timing and available options and approaches for introduction of allergenic foods.
    • 1.00 Contact hours
04/06/2021 to 09/01/2022 $0.00 $10.00
JPHC CE: COVID-19: Impacts and Implications for Pediatric Practice
0.75 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is 10$. Since the rapid emergence of the novel coronavirus in December of 2019 and subsequent development of a global pandemic, clinicians around the world have struggled to understand and respond effectively in health care systems already strained before this latest viral outbreak. Leaders are making policy decisions while balancing the slow and precise nature of science with the rapid need for lifesaving information. Pediatric nurse practitioners are ideally situated as a trusted source of health information for children. This continuing education article summarizes the latest evidence on the rapidly developing coronavirus pandemic. J Pediatr Health Care.(2020) 34, Issue 6, p619-629
    • 0.75 Contact hours
10/27/2020 to 12/31/2021 $0.00 $10.00
JPHC CE: Pediatric Psoriasis Comorbidities: Screening Recommendations for the Primary Care Provider
1.0 NAPNAP Contact Hour of which 0.25 contain Pharmacology content. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is 10$. Psoriasis, which affects up to 2% of children may be associated with significant comorbidity, including obesity, diabetes, cardiovascular disease, depression, and reduced quality of life. Screening and decision-making require a multidisciplinary approach with the management of potential comorbidities championed by primary care providers and supported by respective specialists and subspecialists. Research into the comorbidities and systemic manifestations has generated significant data culminating in several proposals for a consensus guideline for both pediatric and nonpediatric populations. Our aim is to provide a summary targeted to the pediatric primary care provider from the best available evidence when caring for children with psoriasis. J Pediatr Health Care. (2021) 35, 337−350
    • 1.00 Contact hours
05/14/2021 to 06/30/2022 $0.00 $10.00
JPHC CE: Pharmacological Management of Spasticity in Children With Cerebral Palsy
1.5 NAPNAP contact hour of which contain 1.5 pharmacology content and 0.25 controlled substance. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is 10$. Cerebral palsy (CP), a nonprogressive disease of the central nervous system, is the most common motor disability in childhood. Patients with CP often have a multitude of associated comorbidities, including impact on muscle tone. There are four main types of CP, with spastic as the most commonly diagnosed. The American Academy of Neurology and Child Neurology Society released a practice parameter regarding the pharmacological management of CP-related spasticity in 2010. This continuing education review evaluates the available safety and efficacy evidence for oral and parenteral pharmacological agents used to reduce spasticity in children with CP and provides a reference for practitioners managing these patients. J Pediatr Health Care. (2020) 34, 409−509.
    • 1.50 Contact hours
07/31/2020 to 10/31/2021 $0.00 $10.00
Exploring the Risks of Social Media Use in Adolescents
1.0 NAPNAP Contact Hour. This continuing education activity rate is 10$ for NAPNAP Members and for non- members. While technology has brought about advancements in every aspect of ordinary daily life, it has also created risks for the pediatric population not experienced in earlier generations. The use of social media has become common among all age groups, especially adolescents. This course will discuss the risks associated with social media use and the role of the NP in caring for children who participate on social media sites.
    • 1.00 Contact hours
05/09/2019 to 06/30/2021 $10.00 $10.00
JPHC CE: Online Sexual Solicitation of Children and Adolescents
0.75 NAPNAP contact hours. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is 10$. The Internet is a relatively new and unregulated entity that can place children and adolescents at risk for a variety of negative and potentially dangerous exposures. One such risk is online sexual solicitations and interactions with older adolescents, peers, and adults. This continuing education article will explore online sexual solicitation of child and adolescents in terms of definition, epidemiology, predictors, consequences, and implications for practice. JPediatr Health Care. (2020) 34, Issue 6, p610−618
    • 0.75 Contact hours
10/28/2020 to 12/31/2021 $0.00 $10.00
Vaping in School: Addressing the Nicotine Use Epidemic Among Middle and High School Youth
1.0 NAPNAP Contact Hour. This continuing education activity rate is 10$. Flavored e-cigarette products are more attractive to kids than cigarettes but are still addicting them to nicotine—and almost half of kids who begin vaping start smoking cigarettes as well. According to the CDC and the National Youth Tobacco Survey, youth e-cigarette use increased tenfold between 2011 and 2015 and the rate of use continues to accelerate. Yet most middle and high school kids, their parents and teachers are not aware that vaping products contain nicotine and are not harmless. This course will inform you about the risks associated with this trend and arm you with strategies to bring to your practices, schools and communities to spread the message that vaping products contain nicotine, which causes addiction, may harm brain development and lead to continued tobacco product use by youth.
    • 1.00 Contact hours
05/13/2019 to 06/30/2021 $10.00 $10.00
Pediatric Primary Care Headache Evaluation
1.0 NAPNAP Contact Hour, 0.25 Pharmacology Hour. This continuing education activity rate is 10$ for NAPNAP Members and for non- members. This course will feature an exemplar, a clinical pathway to guide initial pediatric headache evaluation and management in primary care. The clinical pathway is a clinical decision support tool to bridge the evidence to practice gap, using evidence-based therapies to provide appropriate, consistent treatment interventions, while improving the quality of care. The step-by-step process of the development and implementation of the clinical pathway will be illustrated.
    • 1.00 Contact hours
05/16/2019 to 06/30/2021 $10.00 $10.00
JPHC CE: Oral b-Lactam Antibiotics for Pediatric Otitis Media, Rhinosinusitis, and Pneumonia
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is 10$. Acute otitis media, acute bacterial rhinosinusitis, and community- acquired pneumonia are major drivers of pediatric antibiotic consumption. With many available options and the added challenges of navigating antibiotic allergies and de-escalating from intravenous treatment for children requiring hospitalization, prescribing for these relatively simple infections can be a source of confusion and error. The purpose of this article is to evaluate the pharmacokinetic and pharmacodynamic properties of antibiotics commonly prescribed for these disease states, and to specifically compare anti-pneumococcal activity between oral beta-lactams. J Pediatr Health Care. (2019) V34, Issue 3 pgs. 291−300
    • 1.00 Contact hours
04/13/2020 to 06/30/2021 $0.00 $10.00
Pediatric Heart Failure
1.0 Contact Hour. This continuing education activity rate is 10$ for NAPNAP Members and for non- members. The Acute Care SIG is pleased to present this offering regarding cardiomyopathy and pediatric heart failure. It is critical that pediatric nurse practitioners are informed about the unique presentation of children in heart failure and the numerous etiologies that may lead to this diagnosis in order to appropriately diagnose and promote optimal outcomes in affected patients. This presentation will describe the pathophysiology, diagnostic strategies, and therapeutic interventions required by this vulnerable population of children and adolescents.
    • 1.00 Contact hours
06/14/2019 to 06/30/2021 $10.00 $10.00
JPHC CE: Caring for the Digital Generation: Understanding Electronic Aggression
1.0 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is 10$. We live in a technology-saturated world, evidenced by widespread, global use of the Internet and other forms of technology. Technology offers nearly limitless connectivity, information-sharing, and communication. Unfortunately, with these opportunities come risks, especially for children, and pediatric healthcare providers have a responsibility to be aware and informed of these risks and how to respond. This article provides a breakdown of the broad phenomenon of electronic aggression and offers practice implications for healthcare providers. J PediatrHealth Care.(2020) Volume 35, Issue 1, p132−140.
    • 1.00 Contact hours
12/17/2020 to 02/28/2022 $0.00 $10.00

Pages